Skip to main content
. 2020 Nov 13;69(45):1706–1710. doi: 10.15585/mmwr.mm6945a7

TABLE 1. Vaccination coverage, by vaccine and World Health Organization (WHO) region — worldwide, 2019.

Vaccine No. (%) of countries with vaccine in schedule WHO region
% coverage*
Global AFR AMR EMR EUR SEAR WPR
BCG
156 (80)
88
80
83
87
92
93
96
DTP1
194 (100)
90
81
90
89
97
94
95
DTP3
194 (100)
85
74
84
82
95
91
94
HepB BD
111 (49)
43
6
55
34
41
54
84
HepB3
189 (97)
85
73
81
82
92
91
94
Hib3
192 (98)
72
73
85
82
79
89
24
HPV, last
106 (55)
15
19
55
0
24
2
4
MCV1
194 (100)
85
69
88
82
96
94
94
MCV2
178 (91)
71
33
75
75
91
83
91
PCV3
148 (74)
48
70
83
52
80
23
14
Pol3
194 (100)
86
74
87
83
95
90
94
RCV1
173 (88)
71
33
88
45
96
93
94
Rota, last§ 108 (52) 39 50 74 49 25 37 2

Abbreviations: AFR = African Region; AMR = Region of the Americas; BCG = bacille Calmette-Guérin vaccine; DTP1 = first dose of diphtheria and tetanus toxoids and pertussis-containing vaccine; DTP3 = third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine; EMR = Eastern Mediterranean Region; EUR = European Region; HepB BD = birth dose of hepatitis B vaccine; HepB3 = third dose of hepatitis B vaccine; Hib3 = third dose of Haemophilus influenzae type b vaccine; HPV, last = final dose of human papillomavirus vaccine; MCV1 = first dose of measles-containing vaccine; MCV2 = second dose of measles-containing vaccine; PCV3 = third dose of pneumococcal conjugate vaccine; Pol3 = third dose of polio vaccine; RCV1 = first dose of rubella-containing vaccine; Rota, last = final dose of rotavirus vaccine series; SEAR = South-East Asia Region; WPR = Western Pacific Region.

* BCG coverage is based on 156 countries with BCG in the national schedule, whereas coverage for all other vaccines is based on 194 countries (global) or all countries in the specified region. Administrative coverage is the number of vaccine doses administered to those in a specified target group divided by the estimated target population. During vaccination coverage surveys, a representative sample of households are visited and caregivers of children in a specified target group (e.g., aged 12–23 months) are interviewed. Dates of vaccination are transcribed from the child's home-based record, recorded based on caregiver recall, or transcribed from health facility records. Survey-based vaccination coverage is calculated as the proportion of persons in a target age group who received a vaccine dose.

Number of doses to complete the HPV series depends on age of recipient.

§ Number of doses to complete the rota series varies among vaccine products.